Quick Links

ART Tag

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text] This is a Phase 3, open-label, multicenter, randomized, active-controlled noninferiority study to evaluate the efficacy and safety of switching to twice-yearly Lenacapavir (LEN) + Teropavimab (TAB) + Zinlirvimab (ZAB) versus continuing stable baseline regimen (SBR) in virologically suppressed...

We are conducting the study to learn more about the physical and mental effects of infection with human immunodeficiency virus (HIV), aging, substance use and the possible effects of antiretroviral medications (ARVs). Participation in the study may or may not benefit you directly, but may...

Interested?

Use the link below to send a message to the study coordinator, or call the number above to speak directly with a study representative.

I am interested in this research study.

SITE PARTNERS